Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) Antibodies:
anti-Mouse (Murine) Antibodies:
Go to our pre-filtered search.
Human Polyclonal LGMN Primary Antibody for WB - ABIN1881495
Clerin, Shih, Deng, Hebert, Resmini, Shields, Feldman, Winkler, Albert, Maganti, Wong, Paulsen, Keith, Vlasuk, Pittman: Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis. in Atherosclerosis 2009
Show all 3 Pubmed References
Human Monoclonal LGMN Primary Antibody for ELISA - ABIN562455
Liu, Bajjuri, Liu, Sinha: Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug. in Molecular pharmaceutics 2012
Human Polyclonal LGMN Primary Antibody for WB - ABIN519319
Garcia-Cattaneo, Gobert, Müller, Toscano, Flores, Lescure, Del Nery, Benaroch: Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling. in Proceedings of the National Academy of Sciences of the United States of America 2012
at the early stage of seed development, deltaVPE is involved in cell death of limited cell layers, the purpose of which is to form a seed coat
Legumain is increased in both plasma and plaques of patients with carotid stenosis and might be a new and early biomarker of atherosclerosis.
Data suggest that melanoma cells internalize/absorb cystatin C (show CST3 Antibodies) from culture media, leading to increased intracellular cystatin C (show CST3 Antibodies) levels; cystatin E/M (show CST6 Antibodies) is internalized as well but at modest rate due to down-regulation of cell migration; however, the effect of intracellular cystatin E/M (show CST6 Antibodies) on down-regulation of legumain activity is pronounced.
AEP is activated and cleaves human alpha-synuclein (show SNCA Antibodies) at N103 in an age-dependent manner.
AEP promotes activation of the PI3K (show PIK3CA Antibodies)-AKT (show AKT1 Antibodies) signaling pathway in prostate cancer cells.
upregulation of legumain is associated with malignant behavior of uveal melanoma.
Studies indicate that legumain, usually in lysosomes, is also found extracellularly and even translocates to the cytosol and the nucleus.
legumain might play an important role in cervical cancer cell migration and invasion.
Legumain appears to be involved in tumor development and deterioration.
AEP acts as a delta-secretase, cleaving APP (show APP Antibodies) at N373 and N585 residues, selectively influencing the amyloidogenic fragmentation of APP (show APP Antibodies). AEP contributes to the age-dependent pathogenic mechanisms in Alzheimer disease.
High legumain expression is associated with breast cancer.
legumain and TIMP-2 (show TIMP2 Antibodies) mRNAs were up-regulated in the endometrium during the luteal phase of the oestrous cycle and during early pregnancy
This study showed that legumain may serve as a biomarker of disease, and that the occurrence of legumain-expressing macrophages in regions of acinar-to-ductal metaplasia suggests that this protease may influence reprogramming events that lead to inflammation-induced pancreatic cancer.
results suggest that legumain expression and activation and cleavage of annexin A2 (show ANXA2 Antibodies) are regulated by DJ-1 (show PARK7 Antibodies) through p53 (show TP53 Antibodies)
AEP acts as a crucial mediator of tau-related clinical and neuropathological changes.
TDP-43 (show TARDBP Antibodies) is cleaved by AEP in brain.
TLR7 (show TLR7 Antibodies) requires a proteolytic cleavage by AEP to generate a C-terminal fragment competent for signaling.
We identified unique expression of asparaginyl endopeptidase (AEP), intercellular adhesion molecule 1 (ICAM1 (show ICAM1 Antibodies)), and ras-related C3 botulinum toxin substrate 2 (RAC2 (show RAC2 Antibodies)), among others, in an invasive pre-B-cell line that produced leukemia in NOD-SCID (show PRKDC Antibodies) mice
AEP is required for normal protein catabolism by PTCs, and its loss induces proliferative and other abnormalities in the murine kidney, at least in part through defective regulation of the EGF receptor (show EGFR Antibodies)
Immunohistochemical analyses revealed the expression of legumain in Iba1 (show AIF1 Antibodies)(+) microglial cells and glial fibrillary acidic protein (show GFAP Antibodies)-positive astrocytes of the peri (show POSTN Antibodies)-infarct area in mice after transient occlusion of the middle cerebral artery.
AEP has a pivotal role in the endosomal/lysosomal degradation system
This gene encodes a cysteine protease that has a strict specificity for hydrolysis of asparaginyl bonds. This enzyme may be involved in the processing of bacterial peptides and endogenous proteins for MHC class II presentation in the lysosomal/endosomal systems. Enzyme activation is triggered by acidic pH and appears to be autocatalytic. Protein expression occurs after monocytes differentiate into dendritic cells. A fully mature, active enzyme is produced following lipopolysaccharide expression in mature dendritic cells. Overexpression of this gene may be associated with the majority of solid tumor types. This gene has a pseudogene on chromosome 13. Several alternatively spliced transcript variants have been described, but the biological validity of only two has been determined. These two variants encode the same isoform.
, asparaginyl endopeptidase
, protease, cysteine 1
, protease, cysteine, 1 (legumain)
, cysteine protease 1
, protease, cysteine, 1